105 related articles for article (PubMed ID: 12579884)
1. [Transdermal microparticle delivery by a supersonic-Helios gun system].
Jin Y; Uchida M; Wang CF; Natsume H; Sugibayashi K; Morimoto Y
Yao Xue Xue Bao; 2001 Feb; 36(2):140-4. PubMed ID: 12579884
[TBL] [Abstract][Full Text] [Related]
2. Transdermal microparticle delivery by a supersonic-Helios gun system.
Yi J; Chao W; Mashaki U; Hideshi N; Yasunori M
Pharmazie; 2004 Dec; 59(12):934-6. PubMed ID: 15638081
[TBL] [Abstract][Full Text] [Related]
3. Introduction of poly-L-lactic acid microspheres into the skin using supersonic flow: effects of helium gas pressure, particle size and microparticle dose on the amount introduced into hairless rat skin.
Uchida M; Jin Y; Natsume H; Kobayashi D; Sugibayashi K; Morimoto Y
J Pharm Pharmacol; 2002 Jun; 54(6):781-90. PubMed ID: 12078994
[TBL] [Abstract][Full Text] [Related]
4. Effects of particle size, helium gas pressure and microparticle dose on the plasma concentration of indomethacin after bombardment of indomethacin-loaded poly-L-lactic acid microspheres using a Helios gun system.
Uchida M; Natsume H; Kobayashi D; Sugibayashi K; Morimoto Y
Biol Pharm Bull; 2002 May; 25(5):690-3. PubMed ID: 12033519
[TBL] [Abstract][Full Text] [Related]
5. Relationships between the particle velocity and introduction of drug-loaded microparticles into the skin in a microparticulate bombardment system.
Uchida M; Natsume H; Seki T; Uchida T; Morimoto Y
Chem Pharm Bull (Tokyo); 2011; 59(5):662-5. PubMed ID: 21532207
[TBL] [Abstract][Full Text] [Related]
6. Immunization by particle bombardment of antigen-loaded poly-(DL-lactide-co-glycolide) microspheres in mice.
Uchida M; Natsume H; Kishino T; Seki T; Ogihara M; Juni K; Kimura M; Morimoto Y
Vaccine; 2006 Mar; 24(12):2120-30. PubMed ID: 16356602
[TBL] [Abstract][Full Text] [Related]
7. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration.
Miyazaki S; Takahashi A; Kubo W; Bachynsky J; Löebenberg R
J Pharm Pharm Sci; 2003; 6(2):238-45. PubMed ID: 12935436
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of indomethacin by iontophoresis.
Kanebako M; Inagi T; Takayama K
Biol Pharm Bull; 2002 Jun; 25(6):779-82. PubMed ID: 12081146
[TBL] [Abstract][Full Text] [Related]
9. pH-sensitive release of indomethacin using lactan-acetate microspheres.
Na K; Lee KY
Drug Dev Ind Pharm; 1998 Jun; 24(6):563-8. PubMed ID: 9876624
[TBL] [Abstract][Full Text] [Related]
10. Effect of pulsed output ultrasound on the transdermal absorption of indomethacin from an ointment in rats.
Asano J; Suisha F; Takada M; Kawasaki N; Miyazaki S
Biol Pharm Bull; 1997 Mar; 20(3):288-91. PubMed ID: 9084890
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery and accumulation of indomethacin in subcutaneous tissues in rats.
Mikulak SA; Vangsness CT; Nimni ME
J Pharm Pharmacol; 1998 Feb; 50(2):153-8. PubMed ID: 9530982
[TBL] [Abstract][Full Text] [Related]
12. Microemulsion: a novel transdermal delivery system to facilitate skin penetration of indomethacin.
Chen L; Tan F; Wang J; Liu F
Pharmazie; 2012 Apr; 67(4):319-23. PubMed ID: 22570938
[TBL] [Abstract][Full Text] [Related]
13. Combination with l-Menthol Enhances Transdermal Penetration of Indomethacin Solid Nanoparticles.
Nagai N; Ogata F; Yamaguchi M; Fukuoka Y; Otake H; Nakazawa Y; Kawasaki N
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349657
[TBL] [Abstract][Full Text] [Related]
14. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
Chauhan AS; Sridevi S; Chalasani KB; Jain AK; Jain SK; Jain NK; Diwan PV
J Control Release; 2003 Jul; 90(3):335-43. PubMed ID: 12880700
[TBL] [Abstract][Full Text] [Related]
15. Controlled systemic delivery of indomethacin using membrane-moderated, cream formulation-based transdermal devices.
Rao PR; Chalasani KB; Chauhan AS; Jain AK; Diwan PV; Ram MK
Drug Deliv; 2006; 13(3):207-13. PubMed ID: 16556573
[TBL] [Abstract][Full Text] [Related]
16. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats.
Kim JY; Ku YS
Int J Pharm; 2000 Jan; 194(1):81-9. PubMed ID: 10601687
[TBL] [Abstract][Full Text] [Related]
17. Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo.
Tomoda K; Terashima H; Suzuki K; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2012 Apr; 92():50-4. PubMed ID: 22154100
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of indomethacin in liposomes.
Stozek T
Acta Pol Pharm; 1992; 49(4):21-6. PubMed ID: 16092430
[TBL] [Abstract][Full Text] [Related]
19. Polycaprolactone Based Nanoparticles Loaded with Indomethacin for Anti-Inflammatory Therapy: From Preparation to Ex Vivo Study.
Badri W; Miladi K; Robin S; Viennet C; Nazari QA; Agusti G; Fessi H; Elaissari A
Pharm Res; 2017 Sep; 34(9):1773-1783. PubMed ID: 28527126
[TBL] [Abstract][Full Text] [Related]
20. Investigation of true nanoemulsions for transdermal potential of indomethacin: characterization, rheological characteristics, and ex vivo skin permeation studies.
Shakeel F; Ramadan W; Ahmed MA
J Drug Target; 2009 Jul; 17(6):435-41. PubMed ID: 19527114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
